Cleopatra Hospitals Group results, Q1 2023
Net profit, assets, equity and cash flow for Q1 2023, against the same period a year earlier, from the published financial statements.
Net profit418 millionEGP · +28.4% vs the same period a year earlier
Total assets4.49 billionEGP · +36.7% vs the same period a year earlier
Shareholders' equity2.45 billionEGP · +20.7% vs the same period a year earlier
Operating cash flow558 millionEGP · +28.0% vs the same period a year earlier
In short
- Cleopatra Hospitals Group's net profit for Q1 2023 was about 418 million EGP, up +28.4% from 326 million EGP in Q1 2022.
- Total assets at the end of Q1 2023 were about 4.49 billion EGP, and shareholders' equity about 2.45 billion EGP.
- Operating cash flow for Q1 2023 was positive at 558 million EGP.
Key lines against the same period a year earlier
This periodQ1 2022Change
Net profit418 million326 million+28.4%
Gross profit1.36 billion1.01 billion+35.2%
Total assets4.49 billion3.28 billion+36.7%
Total liabilities2.04 billion1.26 billion+62.6%
Shareholders' equity2.45 billion2.03 billion+20.7%
Total liabilities and equity4.49 billion3.28 billion+36.7%
Operating cash flow558 million436 million+28.0%
Investing cash flow-798 million-381 million−109.2%
Financing cash flow153 million-555 million+127.5%
Net change in cash15.05 million-500 million+103.0%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Cleopatra Hospitals Group's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy